Safety of MODI Insulin Algorithm for Adults with Diabetes
This study is testing the safety of the MODI Algorithm, a new tool to help manage insulin doses, for adults with type 1 or type 2 diabetes. The MODI Algorithm includes a diary app to view treatment plans and log events like insulin intake and meals, plus a bolus calculator. You might be able to join if you are between 18 and 80 years old, have had diabetes for at least six months, and use insulin therapy. The main goal is to see how well MODI helps keep your blood sugar from going too low (below 54 mg/dL) over 13 weeks. The study plans to enroll 102 participants, but its current recruitment status is unclear.
- Study design
- This is a single-arm study, meaning all participants will receive the MODI Algorithm. It will involve 102 adult participants with type 1 or type 2 diabetes.
- What's involved
- You will use the MODI insulin titration algorithm and a diary app for 13 weeks, following a 2-week period of your usual therapy.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary safety measure is assessed at 13 weeks, indicating the duration of the intervention phase.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
At a glance
Conditions
Where it's being run
6 sites across 6 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- CGM-measured percent time <54mg/dL13 weeks
Change in CGM-measured percent time \<54 mg/dL from 2 weeks of baseline to 4 weeks prior to the dose guidance week 12 visit (non-inferiority with margin 0.5%)